Key facts
- NYBC Ventures is a venture capital firm based in Boston, Massachusetts with 11 tracked portfolio companies.
- Notable positions include AvenCell, Veralox Therapeutics, Immusoft, Akadeum Life Sciences, ViTToria Biotherapeutics.
- The team roster lists 1 person.
About NYBC Ventures
Founded in 2022, NYBC Ventures is the corporate venture capital arm of New York Blood Center, based in Boston, Massachusetts. The firm prefers to invest in early-stage companies operating in the cell therapy, transfusion medicine, benign hematology, and infectious disease sectors, of which emerging technologies, including in-vivo cell therapy, gene editing, iPSC, and regenerative medicine, are of interest.
Free account
See the whole book
- ·The book's top 25 — of 11 recorded positions
- ·Watchlist + alerts for NYBC Ventures's activity
Create free account
No card required
Portfolio, priced
11 companies · by our current valuations| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| AvenCell | — | $227.0M | — | |
| Veralox Therapeutics | — | $66.0M | — | |
| Immusoft | — | $65.2M | — | |
| Akadeum Life Sciences | — | $32.7M | — | |
| ViTToria Biotherapeutics | — | $30.0M | — | |
| STRM.BIO | — | $26.0M | — | |
| KaloCyte | Biotechnology | $24.7M | — | |
| Star Therapeutics | Biotechnology | — | — | |
| TTP | — | — | — | |
| CatenaBio | — | — | — | |
| Vitestro | — | — | — |
Team
1 people on record — 1 with verified contacts
Partners, principals, and the people who answer a pitch. Pro members reveal contacts with credits.
Frequently asked
- What companies does NYBC Ventures invest in?
- NYBC Ventures has 11 recorded portfolio companies, including AvenCell, Veralox Therapeutics, Immusoft, Akadeum Life Sciences.
- What is NYBC Ventures's AUM?
- NYBC Ventures manages approximately $50.0M in assets.